Skip to main content

Table 8 Results of the analysis of tablet formulation of DOX

From: A stability-indicating HPLC method for estimation of doxylamine succinate in tablets and characterization of its major alkaline stress degradation product

Sr. no.

Tablet strength 50 mg

Weight of tablet powder taken (mg)

Amount of drug estimated (mg/tablet)

% Label claim

1

69.0

24.97

99.88

2

69.0

25.05

100.2

3

69.0

24.93

99.72

4

69.0

24.88

99.52

5

69.0

24.96

99.84

6

69.0

25.01

100.04